TradeLink Capital’s Celgene Corp CELG Stock Holding History

TradeLink Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,000	Closed	-$172K	–	424
2014 Q2	$172K	Buy	+2,000	New	+$152K	0.16%	200
2013 Q4	–	Sell	-600	Closed	-$46K	–	294
2013 Q3	$46K	Buy	+600	New	+$42K	0.11%	189

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TradeLink Capital's CELG Position: Q3 2014 in Review

TradeLink Capital sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 2,000 shares — an estimated $172K sold.

TradeLink Capital first reported a position in CELG in Q3 2013 and held it in 2 quarters. The position peaked at $172K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

TradeLink Capital reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
TradeLink Capital sold 2,000 Celgene Corp shares in Q3 2014, an estimated $172K.
TradeLink Capital first reported a position in Celgene Corp in Q3 2013 and held it in 2 quarters.
TradeLink Capital's Celgene Corp position peaked at $172K in Q2 2014.
1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on TradeLink Capital's 13F filing for Q3 2014, filed 27 Oct 2014.